CTTN and acute respiratory distress syndrome: Examples of pathways explored in preclinical models of ALI include S1P receptors and S1P metabolizing enzymes, Abl kinase signaling and imatinib inhibition, and CTTN-MLCK interactions [13,91,92,93,94].